The combination drug acetylsalicylic acid/dipyridamole (trade names Aggrenox, Asasantin) is a drug combination of:[1]
Combination of | |
---|---|
Acetylsalicylic acid | Anticoagulant |
Dipyridamole | Anticoagulant |
Clinical data | |
Trade names | Aggrenox, Asasantin |
AHFS/Drugs.com | UK Drug Information |
Routes of administration | Oral |
ATC code |
|
Identifiers | |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
KEGG |
|
CompTox Dashboard (EPA) |
|
The combination acts as an extended release formulation and is primarily used for platelet inhibition in patients suffering, or at risk from, acute coronary events and stroke.[3] Its use has been shown to be better than the use of either dipyridamole or aspirin alone.[4]